(Q42603284)

English

Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials

scientific article published on 12 June 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

1 reference

based on heuristic

inferred from title

bipolar I disorder

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

1

object named as

Trisha Suppes

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

author name string

Urban Gustafsson

3

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Birgit Ekholm

4

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

publication date

12 June 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Depression and Anxiety

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

1089-1098

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6).

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

New treatment guidelines for acute bipolar depression: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

Atypical antipsychotics in bipolar disorder: systematic review of randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

Achieving and sustaining remission in bipolar I disorder with ziprasidone : a post hoc analysis of a 24-week, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

A rating scale for mania: reliability, validity and sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

A rating scale for drug-induced akathisia

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

Lithium: updated human knowledge using an evidence-based approach: Part I: Clinical efficacy in bipolar disorder

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

Threats to the validity of clinical trials employing enrichment strategies for sample selection

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

The metabolic effects of antipsychotic medications

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

21 January 2018

The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1002%2FDA.22136

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DA.22136

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42603284&oldid=1962581532"